共 122 条
[1]
Iqbal J(2013)Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting EuroIntervention 9 62-69
[2]
Sumaya W(2019)Incidence, angiographic and clinical predictors, and impact of stent thrombosis: a 6-year survey of 6,545 consecutive patients Neth Heart J 27 321-329
[3]
Tatman V(2007)Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2344-2351
[4]
Rozemeijer R(2009)Clinical manifestation and prognosis of early versus late stent thrombosis of drug-eluting stents J Interv Cardiol 22 228-233
[5]
Wing WC(2016)Prevalence and outcomes of early versus late stent thrombosis presenting as ST-segment elevation myocardial infarction Coron Artery Dis 27 667-672
[6]
Leenders G(2013)Contemporary analysis of incidence and outcomes of stent thrombosis presenting as ST elevation myocardial infarction in a primary percutaneous coronary intervention cohort Am J Cardiol 112 1347-1354
[7]
Cutlip DE(2010)Comparisons of baseline demographics, clinical presentation, and long-term outcome among patients with early, late, and very late stent thrombosis of sirolimus-eluting stents: Observations from the Registry of Stent Thrombosis for Review and Reevaluation (RESTART) Circulation 122 52-61
[8]
Windecker S(2014)Comparison of long-term outcome after percutaneous coronary intervention for stent thrombosis between early, late, and very late stent thrombosis Circ J 78 101-109
[9]
Mehran R(2012)Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis JACC Cardiovasc Interv 5 131-140
[10]
Lemesle G(2008)Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos) J Am Coll Cardiol 51 986-990